T1	Participants 164 227	patients with chronic heart failure after myocardial infarction
T2	Participants 364 396	patients with heart failure (HF)
T3	Participants 560 618	patients with class II to IV HF and ejection fraction <35%
T4	Participants 406 412	MARVEL
T5	Participants 773 840	330 patients intended for enrollment, 23 were randomized (MARVEL-1)
